ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1550

Flares of Disease Activity As Risk Factor for the Occurrence of Myocardial Infarction in Patients with Rheumatoid Arthritis

Esmee Bakker1, Pauline Geuijen2, Beata Radovits1, Delia Popa-Diaconu1, Calin Popa1, Elke Arts1, Alfons A. den Broeder3 and Jaap Fransen1, 1Rheumatology, Radboud University Medical Centre, Nijmegen, Netherlands, 2Rheumatology, Radboud University Medical Center, Nijmegen, Netherlands, 3Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cardiovascular disease, Disease Activity, rheumatoid arthritis (RA) and risk

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Clinical Aspects Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) patients have an increased risk of cardiovascular diseases (CVD). The underlying mechanism is partly explained by the inflammation process in both RA and atherosclerosis. Atherosclerosis is an important risk factor for the occurrence of premature coronary heart disease, like myocardial infarction (MI) (1). A higher average level of disease activity in RA patients might cause MI, however this hypothesis was not confirmed (2). Probably, flares are more important than the average level of disease activity as risk factor for CVD in RA. Therefore, the objective was to determine whether the annual flare rate is associated with the occurrence of MI in RA patients.

Methods: We used case-control data from a large Dutch prospective RA cohort, which started in 1985. Medical files of RA patients were used to determine the occurrence of MI events. Patients were defined as cases at the moment they experienced a MI event. Randomly chosen RA controls were matched on disease duration; the time between RA diagnosis and MI event or censoring. Flares were defined as an increase in DAS28>1.2 or >0.6 if DAS28≥3.2. The annual flare rate was calculated as the number of flares divided by disease duration. Other important characteristics of RA and risk factors for CVD were determined at baseline or during follow-up. Characteristics of cases and controls were compared by t-tests or non-parametric Mann-Whitney U. Logistic regression was performed to determine the crude association between the annual flare rate and occurrence of MI. Confounding variables were taken into account using multivariate logistic regression.

Results: The study population consisted of 41 cases and 181 matched controls. Cases were older and more frequently male while also risk factors for CVD were raised in cases, like: significantly higher BMI, total cholesterol, triglyceride, LDL, atherogenic index, incidence of hypertension and, a significantly lower HDL, compared to controls. Other characteristics like smoking status, disease duration, average DAS28, C-reactive protein levels, rheumatoid factor positivity, prevalence of diabetes mellitus, and medication use did not differ significantly between cases and controls. The crude OR of the annual flare rate and the occurrence of MI was 0.78 (95% CI: 0.48; 1.25). The OR adjusted for age, LDL, male gender, cholesterol, hypertension, and HDL was 0.97 (95% CI: 0.58; 1.68).

Conclusion: No significant association was found between annual flare rate and the occurrence of MI in RA patients. This implies that the presence of flares in disease activity does not contribute to the increased CVD risk in RA patients, in contrast to expectations.

1.            Kitas GD, Gabriel SE. Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Annals of the rheumatic diseases. 2011;70(1):8-14.

2.            Radovits BJ, Popa-Diaconu DA, Popa C, Eijsbouts A, Laan RF, van Riel PL, et al. Disease activity as a risk factor for myocardial infarction in rheumatoid arthritis. Annals of the rheumatic diseases. 2009;68(8):1271-6.


Disclosure: E. Bakker, None; P. Geuijen, None; B. Radovits, None; D. Popa-Diaconu, None; C. Popa, None; E. Arts, None; A. A. den Broeder, None; J. Fransen, None.

To cite this abstract in AMA style:

Bakker E, Geuijen P, Radovits B, Popa-Diaconu D, Popa C, Arts E, den Broeder AA, Fransen J. Flares of Disease Activity As Risk Factor for the Occurrence of Myocardial Infarction in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/flares-of-disease-activity-as-risk-factor-for-the-occurrence-of-myocardial-infarction-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/flares-of-disease-activity-as-risk-factor-for-the-occurrence-of-myocardial-infarction-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology